ScreenerHero

ONWD Onward Medical N.V.

EBR · BE · Healthcare · Biotechnology · onwd.com
2.605EUR+1.76%Mkt Cap: 196.87M $P/E: —

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The compa…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap196.87M USD
Enterprise Value121.00M USD
Revenue (TTM)9.15M USD
Gross Profit2.98M USD
Net Income (TTM)-45.42M USD
Revenue/Share0.16 EUR
Last Price2.605 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees137
CountryBE
SectorHealthcare
IndustryBiotechnology
ISINNL0015000HT4
Valuation
P/E (Trailing)—
P/E (Forward)-4.29
PEG—
EV/EBITDA-2.56
EV/Revenue13.22
P/S21.26
P/B2.61
EPS (TTM)-0.85
EPS (Forward)-0.60
52W Range
2.27010% of range5.770
52W High5.770 EUR
52W Low2.270 EUR
Profitability
Gross Margin72.51%
Oper. Margin-556.66%
EBITDA Margin0.00%
Profit Margin-1105.48%
ROE-75.54%
ROA-49.42%
Growth
Revenue Growth253.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-42.46M USD
CapEx (TTM)469.57K USD
FCF Margin-345.15%
FCF Yield-16.05%
Net Debt-73.60M USD
Net Debt/EBITDA1.56
Balance Sheet
Debt/Equity0.25
Current Ratio9.23
Quick Ratio8.60
Book Value/Sh0.99 EUR
Cash/Share1.17 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)9.240 EUR
Upside (mean)+254.7%
Target Range8.100 EUR – 11.00 EUR
8.100+254.7% to mean11.00
# Analysts5
Ownership
Shares Out.69.53M
Float54.66M
Insiders27.05%
Institutions24.08%
Technical
SMA 502.520 (+3.4%)
SMA 2003.156 (-17.5%)
Beta0.85
S&P 52W Chg14.58%
Avg Vol (30d)174.09K
Avg Vol (10d)100.66K
Technical Indicators
RSI (14)47.2
MACD0.0173
MACD Signal0.0515
MACD Hist.-0.0342
BB Upper2.928 EUR
BB Middle2.732 EUR
BB Lower2.535 EUR
BB Width14.40%
ATR (14)0.0993 EUR
Vol Ratio (20d)0.23x